Sanner Expands Global Footprint with First US Manufacturing Facility

German healthcare packaging and device CDMO Sanner has inaugurated its first manufacturing facility in the United States, marking a significant expansion of its global operations. The new plant, located in Greensboro, North Carolina, represents a strategic move to strengthen the company's presence in the North American market and enhance its capabilities in advanced manufacturing for the pharmaceutical and medical device industries.

State-of-the-Art Facility Bolsters Sanner's US Presence

The newly opened Greensboro facility spans over 60,000 square feet and features GMP-certified clean rooms equipped with cutting-edge technology for advanced auto injection molding and high-speed desiccant filling. This expansion comes on the heels of Sanner's recent acquisitions in the US market, including the purchase of medtech CDMO Gilero in September and Springboard Pro in early 2024.

Christian Classen, Sanner's Chief Sales Officer, emphasized the significance of this development, stating, "This is more than just a new facility. It's a bold step forward in our global journey, reinforcing our long-term commitment to supporting our customers in North America with local production, cutting-edge technology, and world-class service."

North Carolina's Growing Life Sciences Hub

Sanner's choice of North Carolina for its US debut aligns with the state's burgeoning reputation as a life sciences powerhouse. The region has attracted significant investments from pharmaceutical giants and contract development and manufacturing organizations (CDMOs) in recent years.

Notable players with key facilities in North Carolina include Eli Lilly, Fujifilm Biotechnologies, and Thermo Fisher Scientific. The state has also seen substantial commitments from other industry leaders:

• Biogen recently unveiled a $2 billion investment plan for new production facilities and upgrades to existing campuses at Research Triangle Park.
• Amgen announced a $1 billion investment in December to construct a second drug substance plant in the state.
• Johnson & Johnson revealed a $2 billion expansion project in North Carolina last October.

Global Expansion and Future Plans

With a 134-year history, Sanner has been rapidly expanding its global footprint in recent years. The company established its dedicated medical device CDMO unit in 2019 and now operates facilities in Germany, France, Hungary, and China, in addition to the new US location.

The Greensboro plant includes an additional 20,000 square feet of space reserved for future expansions, indicating Sanner's long-term growth strategy in the region. Furthermore, the company has announced plans to construct a second manufacturing facility in China, further solidifying its position as a global player in the pharmaceutical packaging and medical device manufacturing sectors.